Skip to main content
Clinical Trials/NCT05704946
NCT05704946CompletedNot Applicable

The Effect of Lavender Inhalation on Sleep Quality in Individuals With Coronary Heart Disease: a Randomized Controlled Study

Cukurova University2 sites in 1 country61 target enrollmentStarted: February 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
61
Locations
2
Primary Endpoint
Effect of lavender inhalation on sleep quality

Study Overview

Brief Summary

The study is planned to be conducted as a two-group randomized controlled trial to determine the effect of lavender inhalation on individuals with coronary heart disease. Research data will be collected at Çukurova University Medical Faculty Balcalı Hospital Cardiology Clinic between January-June 2023. In the study, at least 56 samples were found to be sufficient for the sample size. The data of the study will be collected using the Personal Information Form and the Pittsburg Sleep Quality Index.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
21 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Able to understand and speak Turkish,
  • Who agreed to participate in the research

Exclusion Criteria

  • People with communication difficulties and mental retardation
  • People with coagulation disorders
  • People with migraines and chronic headaches
  • People with an allergy to lavender (Lavandula angustifolia Mill)
  • It is the desire to leave the research.

Outcomes

Primary Outcomes

Effect of lavender inhalation on sleep quality

Time Frame: one months

The index includes 24 questions that evaluate the quality of sleep and the type and severity of sleep disorders experienced in the last 1 month period. The total score in the index takes a value between 0-21. If the total score is higher than 5, it is interpreted as poor sleep quality.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sevgi Deniz Dogan

assistant professor

Cukurova University

Study Sites (2)

Loading locations...

Similar Trials